Insider buying last 90 days
$251Kin 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Nov 12 | Kanouff Yvette director | Purchase | $101K |
| Nov 12 | Genish Amos director | Purchase | $150K |
From Form 4 filings, dated to when each was filed.
Nov 13 close
Amdocs closed at $41.74 on 9 November 2026, -0.8% on the day. The price sits below both the 50-day ($59.07) and 200-day ($61.59) moving averages, inside a 52-week range of $40.48 to $85.63. The GekkoIndex reads 81.5, in the Buying zone, up 32.5 points over five sessions. Gekko Fair Value is $83.99, so the price is 50.3% below it.
The next earnings report is due on 2 February 2027, 79 days away (after close). Over the last 8 reports the company beat the earnings estimate 6 times, with an average move of 7.9% across the report. Seasonally, the next 20 trading days from this point averaged -1.8% over the last 5 years, rising in 2 of them.
1 firms rate the stock: 0 buy, 1 hold and 0 sell, with a consensus target of $73.00. A typical daily move is about 7.6%, and a typical 20-day move about 4.1%. On the swing-trade checklist, 3 items read supportive and 2 read as a headwind (trend, seasonality).
A plain summary of the figures as of the Nov 9, 2026 close.
Amdocs scores 5 supportive, 0 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
5 supportive0 mixed1 headwind
Below 50 and 200-day
Close $44.79 is below the 50-day ($57.51) and 200-day ($60.82) averages, and the 50-day is below the 200-day.
See the chart69.2, Accumulation
Reading 69.2 is in the Accumulation zone.
See the GekkoIndex43.0% below
Price is 43% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 2 open-market insider purchases.
See smart moneyReports in 79 days
Next report Feb 2, 2027, 79 days away — outside a typical 20-trading-day hold.
See earnings+3.3% on average
From this point in the calendar, the next 20 trading days averaged +3.3% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Amdocs closed at $44.79 on Nov 13, 2026, −42.1% over the past year, inside a 52-week range of $39.96 to $84.95.
Use the left and right arrow keys to read daily values.
Put DOX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Amdocs designs cloud-based software that helps service providers manage how they build, deliver and bill for their offerings. One of its best-known products, CES21, gives providers a way to shape customer experiences using 5G and cloud-native microservices technology, so they can launch and profit from newer kinds of services. Its catalog also includes tools for handling orders and customer interactions, systems for charging and revenue management, a suite for automating network operations, a cloud-native platform called MarketONE, a package aimed at smaller or emerging telecom brands, and software for managing eSIMs, along with AI-based home operating systems and data intelligence tools.
The company also supplies services that support providers throughout their operations, from initial design and integration to consulting, mobile network work and content-related tasks. A separate managed services offering covers building, updating and maintaining applications, along with IT support, testing and other professional work, aimed at helping clients run and maintain their technology systems. Its customer base includes companies in communications, cable, satellite, entertainment and media, as well as mobile virtual network operators and directory publishers.
Amdocs traces its founding to 1988 and is headquartered in Saint Louis, Missouri. Its stock trades on the NASDAQ under the ticker DOX.
Amdocs’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 69.2, in the Accumulation zone, down 12.2 points over five sessions.
Down 12.2 points over five sessions, from the Buying zone.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 54 | −0.8% | −1.0% | ||
| Accumulation (current zone) | 259 | −0.2% | −0.4% | ||
| Neutral | 371 | −0.2% | −1.4% | ||
| Distribution | 16 | −3.5% | −3.6% | ||
| Selling | 2 | Too few readings yet | |||
Average DOX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Amdocs trades 43.0% below Gekko Fair Value of $78.56, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Amdocs shares are worth, recalculated every trading day.
$78.56
Gekko Fair Value, Nov 14, 2026
43.0% Undervalued
At the end of Aug 2026 the price was 26.9% below the estimate.
Insiders filed 2 open-market purchases in Amdocs worth $251K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$251Kin 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Nov 12 | Kanouff Yvette director | Purchase | $101K |
| Nov 12 | Genish Amos director | Purchase | $150K |
From Form 4 filings, dated to when each was filed.
No trades in DOX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Amdocs has been buying back its own shares.
From company filings.
Amdocs reports on Feb 2, 2027, after the close (79 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 2, 2027
Expected after the close, 79 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Nov 3, 2026 | $1.98 est $1.98 | $1.19B est $1.19B | −31.3% |
| Aug 5, 2026 | $1.84 est $1.84 | $1.17B est $1.18B | +4.2% |
| May 13, 2026 | $1.78 est $1.76 | $1.17B est $1.17B | −0.7% |
| Feb 3, 2026 | $1.81 est $1.76 | $1.16B est $1.15B | −9.8% |
| Nov 11, 2025 | $1.83 est $1.82 | $1.15B est $1.15B | −9.5% |
| Aug 6, 2025 | $1.72 est $1.71 | $1.14B est $1.15B | +4.8% |
| May 7, 2025 | $1.78 est $1.70 | $1.13B est $1.16B | +2.3% |
| Feb 4, 2025 | $1.66 est $1.64 | $1.11B est $1.12B | +0.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Amdocs is $57.33, +28.0% from the last close, from 1 firm rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 1 firm.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 3 | Oppenheimer | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Amdocs averaged +3.3% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.6% | 2 of 5 |
| Next 10 trading days | −0.3% | 2 of 5 |
| Next 15 trading days | +1.5% | 2 of 5 |
| Next 20 trading days | +3.3% | 4 of 5 |
| Next 30 trading days | +4.4% | 4 of 5 |
For scale, DOX’s typical 20-trading-day move in either direction is about 4.2%.
Amdocs’s market cap is $4.82B, with a P/E ratio of 9.4 and revenue of $4.70B over the last twelve months.
Coverage of Amdocs this week reads neutral: 4 positive, 10 neutral and 2 negative headlines.
Amdocs’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| IBMInternational Business Machines | Neutral | 6.0% below |
| ACNAccenture | Neutral | 5.6% above |
| NETCloudflare | Neutral | 2.1% above |
| FTNTFortinet | Accumulation | 5.8% above |
| WDAYWorkday | Neutral | 14.2% above |
| CTSHCognizant Technology Solutions | Neutral | 21.3% below |
A peer links to its own page where one exists.
Amdocs’s market cap is $4.82B at the Nov 13, 2026 close of $44.79, with 104.4M shares outstanding. The shares trade on a P/E ratio of 9.4.
The consensus analyst 12-month price target for Amdocs is $57.33, +28.0% from the last close. Of the 1 firm that rated the stock in the last 90 days, 0 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Amdocs is undervalued: the Nov 13, 2026 close of $44.79 is 43.0% below Gekko Fair Value of $78.56. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Amdocs is expected to report on Feb 2, 2027, after the market closes (79 days away). Analysts expect earnings of $1.30 per share on revenue of $972.8M. Amdocs beat the earnings estimate in 6 of its last 8 reports, moving 7.9% on average across the report.
Amdocs’s 52-week high is $84.95 and its 52-week low is $39.96; it closed at $44.79 on Nov 13, 2026, −42.1% over the past year. Over the last five years the shares peaked at $99.75 on Jun 30, 2023.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 5 of the 6 items with data read as supportive (gekkoindex, fair value, smart money, earnings risk and seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.